Editorial: Mitochondria at the nexus of metabolism, aging, and disease

Karthik Babu Mallilankaraman; Brian K Kennedy; Vincenzo Sorrentino; Alessandro Luciani

doi:10.3389/fcell.2023.1356278

Editorial: Mitochondria at the nexus of metabolism, aging, and disease

Front Cell Dev Biol. 2024 Jan 11:11:1356278. doi: 10.3389/fcell.2023.1356278. eCollection 2023.

Authors

Karthik Babu Mallilankaraman^{1

2}, Brian K Kennedy^{1

2

3}, Vincenzo Sorrentino^{2

3}, Alessandro Luciani⁴

Affiliations

¹ Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
² Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
³ Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
⁴ Mechanisms of Inherited Kidney Disorders Group, Institute of Physiology, University of Zurich, Zurich, Switzerland.

No abstract available

Keywords: ageing; dietary intervention; drug discovery; metabolic disease; metabolic signaling; metabolism; mitochondrial dysfuncion; mitophagy.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. VS is supported by the NUHS Internal Grant Funding under NUS Start-up grant NUHSRO/2022/047/Startup/11. AL is supported by the Swiss National Science Foundation (project grant 310030_215715); by the Cystinosis Research Foundation (Irvine, CA, United States; project grants, CRFS-2020-005, CRFS-2022-003, and CRFS-2023-003), and by the University Research Priority Program of the University of Zurich (URPP) ITINERARE—Innovative Therapies in Rare Diseases. BK is supported by the grants from NUHS ODPRT HLTRP/2021/Rethinking-old-drugs-002; KM is supported by the grants from NUHS ODPRT HLTRP/2021/Rethinking-old-drugs-002 and MOE Tier 1/NUHS Seed fund/2022.